ARMEN GARO H
SEC insider (Form 3/4/5 filer). CIK 0000935679. Director at AGENUS INC (AGEN) and 1 other issuer. 62 reported Form 4/5 transactions since Sep 2024; latest on Aug 21, 2026. Located in LEXINGTON, MA.
Companies ARMEN GARO H has filed insider reports for
- AGENUS INC (AGEN): Director, Officer, See Remarks
- Protagenic Therapeutics, Inc.\new (PTIX): Director, Officer, EXEC. CHAIR & PRINCIPAL OFF.
ARMEN GARO H
CIK: 0000935679
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (62 total)
- Aug 21, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect20K shares at avg. $0.65$13K - Aug 20, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect16.6K shares at avg. $0.59$10K - Aug 19, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect2.7K shares at avg. $0.35$945 - Aug 11, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect2.2K shares at avg. $0.32$710.4 - Aug 10, 2026AGEN
AGENUS INC
AwardDirectStock Option
2M shares- - Aug 6, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect685 shares at avg. $0.22$150.7 - Aug 5, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect5K shares at avg. $0.26$1K - Jul 30, 2026PTIX
Protagenic Therapeutics, Inc.\new
PurchaseDirect26.3K shares at avg. $0.18$5K - Jul 10, 2026AGEN
AGENUS INC
AwardDirect4.9K shares at avg. $3.35$16K - Jun 12, 2026AGEN
AGENUS INC
AwardDirect4.9K shares at avg. $3.30$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 |  PTIX Protagenic Therapeutics, Inc.\new | Purchase | 20,000 | $0.65 | $13,000 | Direct |
| Aug 20, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 16,634 | $0.59 | $9,811 | Direct |
| Aug 19, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 2,700 | $0.35 | $945 | Direct |
| Aug 11, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 2,220 | $0.32 | $710 | Direct |
| Aug 10, 2026 |  AGEN AGENUS INC | Award Stock Option | 1,971,500 | - | - | Direct |
| Aug 6, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 685 | $0.22 | $151 | Direct |
| Aug 5, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 5,000 | $0.26 | $1,294 | Direct |
| Jul 30, 2026 | PTIX Protagenic Therapeutics, Inc.\new | Purchase | 26,291 | $0.18 | $4,806 | Direct |
| Jul 10, 2026 | AGEN AGENUS INC | Award | 4,852 | $3.35 | $16,254 | Direct |
| Jun 12, 2026 | AGEN AGENUS INC | Award | 4,925 | $3.30 | $16,253 | Direct |
1-10 of 62 transactions